Investigation of the safety and feasibility of AAV1/SERCA2a gene transfer in patients with chronic heart failure supported with a left ventricular assist device - the SERCA-LVAD TRIAL.

Autor: Lyon AR; National Heart and Lung Institute, Imperial College London, London, UK. a.lyon@imperial.ac.uk.; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield Hospitals NHS Trust, London, UK. a.lyon@imperial.ac.uk., Babalis D; Imperial Clinical Trials Unit (ICTU), School of Public Health, Imperial College London, London, UK., Morley-Smith AC; National Heart and Lung Institute, Imperial College London, London, UK.; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield Hospitals NHS Trust, London, UK., Hedger M; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield Hospitals NHS Trust, London, UK., Suarez Barrientos A; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield Hospitals NHS Trust, London, UK., Foldes G; National Heart and Lung Institute, Imperial College London, London, UK., Couch LS; National Heart and Lung Institute, Imperial College London, London, UK., Chowdhury RA; National Heart and Lung Institute, Imperial College London, London, UK., Tzortzis KN; National Heart and Lung Institute, Imperial College London, London, UK., Peters NS; National Heart and Lung Institute, Imperial College London, London, UK., Rog-Zielinska EA; National Heart and Lung Institute, Imperial College London, London, UK.; Institute for Experimental Cardiovascular Medicine, University Heart Center, Medical Center, University of Freiburg, Freiburg, Germany., Yang HY; National Heart and Lung Institute, Imperial College London, London, UK., Welch S; National Heart and Lung Institute, Imperial College London, London, UK.; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield Hospitals NHS Trust, London, UK., Bowles CT; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield Hospitals NHS Trust, London, UK., Rahman Haley S; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield Hospitals NHS Trust, London, UK., Bell AR; Department of Histopathology, Royal Brompton and Harefield Hospitals NHS Trust, Freiburg, Germany., Rice A; Department of Histopathology, Royal Brompton and Harefield Hospitals NHS Trust, Freiburg, Germany., Sasikaran T; Imperial Clinical Trials Unit (ICTU), School of Public Health, Imperial College London, London, UK., Johnson NA; Imperial Clinical Trials Unit (ICTU), School of Public Health, Imperial College London, London, UK., Falaschetti E; Imperial Clinical Trials Unit (ICTU), School of Public Health, Imperial College London, London, UK., Parameshwar J; Royal Papworth Hospital NHS Trust, Cambridge, UK., Lewis C; Royal Papworth Hospital NHS Trust, Cambridge, UK., Tsui S; Royal Papworth Hospital NHS Trust, Cambridge, UK., Simon A; National Heart and Lung Institute, Imperial College London, London, UK.; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield Hospitals NHS Trust, London, UK., Pepper J; National Heart and Lung Institute, Imperial College London, London, UK.; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield Hospitals NHS Trust, London, UK., Rudy JJ; Celladon Corporation, San Diego, CA, USA., Zsebo KM; Celladon Corporation, San Diego, CA, USA., Macleod KT; National Heart and Lung Institute, Imperial College London, London, UK., Terracciano CM; National Heart and Lung Institute, Imperial College London, London, UK., Hajjar RJ; Phospholamban Foundation, Amsterdam, Netherlands., Banner N; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield Hospitals NHS Trust, London, UK., Harding SE; National Heart and Lung Institute, Imperial College London, London, UK.

Publikováno v: Gene therapy [Gene Ther] 2020 Dec; Vol. 27 (12), pp. 579-590. Date of Electronic Publication: 2020 Jul 15.

CCCTC-binding factor mediates effects of glucose on beta cell survival.

Autor: Tsui S; Department of Medicine, David Geffen School of Medicine University of California Los Angeles, Torrance, CA, 90502, USA., Dai W, Lu L

Publikováno v: Cell proliferation [Cell Prolif] 2014 Feb; Vol. 47 (1), pp. 28-37. Date of Electronic Publication: 2013 Dec 20.

Do peer educators make a difference? An evaluation of a youth-led HIV prevention model in Zambian Schools.

Autor: Denison JA; Behavioral.iomedical Research, Family Health International, Durham, NC 27713, USA. jdenison@fhi.org, Tsui S, Bratt J, Torpey K, Weaver MA, Kabaso M

Publikováno v: Health education research [Health Educ Res] 2012 Apr; Vol. 27 (2), pp. 237-47. Date of Electronic Publication: 2011 Oct 10.

Transforming growth factor beta1 and laminin-111 cooperate in the induction of interleukin-16 expression in synovial fibroblasts from patients with rheumatoid arthritis.

Autor: Warstat K; Center for Regenerative Medicine and Department of Orthopaedic Surgery, Center for Medical Research, D 72072 Tübingen, Germany., Hoberg M, Rudert M, Tsui S, Pap T, Angres B, Essl M, Smith TJ, Cruikshank WW, Klein G, Gay S, Aicher WK

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2010 Jan; Vol. 69 (1), pp. 270-5.

Current differences in referral patterns for pulmonary endarterectomy in the UK.

Autor: Toshner M; Papworth Hospital NHS Trust, Papworth Everard, Bath, UK., Suntharalingam J, Goldsmith K, Niggebrugge A, Pepke-Zaba J, Morrell NW, Tsui S, Flowers J, Jenkins D

Publikováno v: The European respiratory journal [Eur Respir J] 2008 Sep; Vol. 32 (3), pp. 660-3.